John Hendrick, President, Safeco

07/20/19 • 38 min

Mr. Hendrick has over three decades of executive experience, building both early-stage medical device companies as well as large divisions in medical device corporations. Currently, Mr. Hendrick is president of Safeco a medical device consulting company. Previously, he was CEO of Mynosys Cellular Devices —an ophthalmic company. Prior to that, he was CEO at NeoVista Inc. —a company in the field of age-related macular degeneration. Prior to that, he created the medical division at Sanmina-Sci. Mr. Hendrick has been through a successful IPO of VidaMed; which led eventually to Medtronic acquiring the company. Prior to VidaMed, Mr. Hendrick held executive positions at Allergan Medical Optics, Baxter, and American Hospital Supply along with several board positions.

Previous Episode

Rahul Modi, Founder and CEO, Envision

Rahul is a health-tech optimist, serial entrepreneur, and biomedical engineer. His affinity for (sensible) innovation is only challenged by his predilection for building customer-obsessed companies. He's a dream-catcher with unbridled curiosity and a strong operator who enjoys delivering value in large markets ripe for change. Humble beginnings not only keep him anchored, but shape the distinct perspective he brings to the table.

More recently, Rahul was the director and founding member of EyeNetra – an MIT Media Lab spinout recognized worldwide for pioneering smartphone-powered refractions to serve the 4.5B individuals in need of vision correction. It's commonly cited that more than half of said populace remains uncorrected to this day. At EyeNetra, he contributed to the development of 4 products from inception, honed their go-to-market strategy, and architected a successful platform for global growth. Thousands of units were both sold and shipped to eye care professionals in over 90 countries within a span of 36 months. By maintaining lean operations, the company eventually became cash flow positive – a rarity at the intersection of hardware, software, and healthcare in an overcapitalized climate. The team also explored a first of its kind model for teleoptometry and spent years in deep R&D, clinical trials, regulatory approvals, and manufacturing prior to commercialization. Confronted along the way were countless moments fraught with uncertainty including an abundance of failures. To-date, this technology suite has facilitated 5 million refractions and a quarter-million connected exams (and counting). It would be remiss not to mention the smiles conjured of millions more from the friends, families, and caretakers of patients.

Next Episode

Guillaume Corpart, Founder & CEO, Global Health Intelligence (GHI)

Guillaume Corpart is the Founder and CEO of Global Health Intelligence. With over 20 years’ business consulting experience, Mr. Corpart supports life-science companies in their growth plans throughout emerging markets.
Global Health Intelligence developed HospiScope – the world’s largest hospital database focused on Latin America, with profiles on over 18,000 hospitals in the region. Through HospiScope medical equipment manufacturers can increase visibility into market opportunities and key accounts.

Through ShareScope clients can determine market size & share of both medical equipment and medical devices with over 90% accuracy. In 2018, Global Health Intelligence launched SurgiScope – detailing procedure volumes by hospital and thus enabling device manufacturers to identify targeted opportunities by account.

In 2011, Mr. Corpart was awarded the Prix Releve Excellence from l’Ecole des Hautes Etudes Commerciales and in 2014 Mr. Corpart received the Outstanding Business Award from the Canadian Chamber of Commerce in Mexico. Mr. Corpart has a B.A. in Marketing and Entrepreneurship from l’Ecole des Hautes Etudes Commerciales (Montreal, Canada) and in 2017 pursued a degree in Scaling Businesses at the Stanford School of Business (California, USA). Mr. Corpart is fluent in English, French and Spanish.